Skip to main content
Fig. 1 | Surgical and Experimental Pathology

Fig. 1

From: Predictive biomarkers in colorectal adenocarcinoma – a Brazilian perspective on current and future practices

Fig. 1

Mismatch repair immunohistochemistry in colorectal cancer. In a proficient tumor, intact nuclear staining of MSH2, MSH6, MLH1 and PMS2 is expected. The case depicted shows retained expression of MSH2 (a) and MSH6 (b) and concomitant losses of MLH1 (c) and PMS2 (d) (i.e., a dMMR case). Staining in background stromal cells and lymphocytes serves as positive internal control and validates the quality of the immunohistochemical reaction. dMMR: deficient mismatch repair. Original magnification 200x

Back to article page